Holcim AG (HOLN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 63.60 |
|---|---|
| 52-week range | 60.10 – 82.54 |
| Return, 1 month / 3 months | −6.5% / −14.5% |
| Return, 1 year / 3 years | −4.7% / +149.6% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 29.1% |
| Worst drawdown (1 year) | -24.7% |
| Average daily value traded | 71.85M CHF |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Holcim is a building materials company based in Switzerland. It makes cement, aggregates such as crushed stone and sand, and ready-mix concrete, and it supplies related products and services for construction projects. Its customers include builders, contractors, developers and infrastructure owners in many countries around the world. The company serves residential, commercial and public construction markets, and its operations span cement production, quarrying and the delivery of concrete to building sites.
Holcim AG trades under the code HOLN on the SIX Swiss Exchange in Switzerland, with its price quoted in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Holcim AG (HOLN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 63.60 on 22 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 142 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.7% and over the last three months it fell 14.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 25 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -10.5% | ||
| From 52-week high | -22.5% | ||
| Momentum | 28 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.5% | ||
| 6-month return | -8.8% | ||
| 12-month return, skipping the last month | 2.0% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.7% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 71.85M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 57 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −6.5% |
| 3 months | −14.5% |
| 6 months | −8.8% |
| 1 year | −4.7% |
| 3 years | +149.6% |
| 5 years | +232.8% |
Signals
| 50-day / 200-day average | 68.24 / 71.07 |
|---|---|
| Golden / death cross (60 days) | Death, 24 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.43 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 May 2026 | CHF 1.7000 |
| 19 May 2025 | CHF 1.5752 |
| 13 May 2024 | CHF 1.4227 |
| 9 May 2023 | CHF 1.2703 |
| 9 May 2022 | CHF 1.1179 |
| 7 May 2021 | CHF 1.0162 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.